img

Global Renal Biomarkers Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Renal Biomarkers Market Insights, Forecast to 2034

Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Market Analysis and InsightsGlobal Renal Biomarkers Market
Global Renal Biomarkers market is expected to reach to US$ 1233.2 million in 2023, with a positive growth of %, compared with US$ 1168.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Renal Biomarkers industry is evaluated to reach US$ 1643.2 million in 2033. The CAGR will be 4.9% during 2023 to 2033.
The major factors fuelling the global renal biomarkers market are increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities.
Report Covers
This report presents an overview of global Renal Biomarkers market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Renal Biomarkers market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Diagnostics
F. Hoffmann-La Roche
Beckman Coulter
Siemens Healthcare Diagnostics
Thermo Fisher Scientific
Astute Medical
BioMerieux SA
Randox Laboratories
Diagnostics A/S
Sphingo Tec GmbH
Eli Lilly and Company
Novartis AG
Gentian Diagnostic
Proteomics International
BioPorto
Segment by Type
Enzyme Linked Immunosorbent Assay (ELISA)
Enzymatic Assay
Turbidimetric Immunoassay
Others

Segment by Application


Diagnosis and Disease Progression Monitoring
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Renal Biomarkers introduction, etc. Renal Biomarkers Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Renal Biomarkers
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.3 Enzymatic Assay
1.2.4 Turbidimetric Immunoassay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Renal Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Diagnosis and Disease Progression Monitoring
1.3.3 Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Biomarkers Market Perspective (2018-2033)
2.2 Global Renal Biomarkers Growth Trends by Region
2.2.1 Renal Biomarkers Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Renal Biomarkers Historic Market Size by Region (2018-2023)
2.2.3 Renal Biomarkers Forecasted Market Size by Region (2024-2033)
2.3 Renal Biomarkers Market Dynamics
2.3.1 Renal Biomarkers Industry Trends
2.3.2 Renal Biomarkers Market Drivers
2.3.3 Renal Biomarkers Market Challenges
2.3.4 Renal Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Renal Biomarkers by Players
3.1.1 Global Renal Biomarkers Revenue by Players (2018-2023)
3.1.2 Global Renal Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Renal Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Renal Biomarkers, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Renal Biomarkers Market Concentration Ratio
3.4.1 Global Renal Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Biomarkers Revenue in 2022
3.5 Global Key Players of Renal Biomarkers Head office and Area Served
3.6 Global Key Players of Renal Biomarkers, Product and Application
3.7 Global Key Players of Renal Biomarkers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Biomarkers Breakdown Data by Type
4.1 Global Renal Biomarkers Historic Market Size by Type (2018-2023)
4.2 Global Renal Biomarkers Forecasted Market Size by Type (2024-2033)
5 Renal Biomarkers Breakdown Data by Application
5.1 Global Renal Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Renal Biomarkers Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Renal Biomarkers Market Size (2018-2033)
6.2 North America Renal Biomarkers Market Size by Type
6.2.1 North America Renal Biomarkers Market Size by Type (2018-2023)
6.2.2 North America Renal Biomarkers Market Size by Type (2024-2033)
6.2.3 North America Renal Biomarkers Market Share by Type (2018-2033)
6.3 North America Renal Biomarkers Market Size by Application
6.3.1 North America Renal Biomarkers Market Size by Application (2018-2023)
6.3.2 North America Renal Biomarkers Market Size by Application (2024-2033)
6.3.3 North America Renal Biomarkers Market Share by Application (2018-2033)
6.4 North America Renal Biomarkers Market Size by Country
6.4.1 North America Renal Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Renal Biomarkers Market Size by Country (2018-2023)
6.4.3 North America Renal Biomarkers Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Renal Biomarkers Market Size (2018-2033)
7.2 Europe Renal Biomarkers Market Size by Type
7.2.1 Europe Renal Biomarkers Market Size by Type (2018-2023)
7.2.2 Europe Renal Biomarkers Market Size by Type (2024-2033)
7.2.3 Europe Renal Biomarkers Market Share by Type (2018-2033)
7.3 Europe Renal Biomarkers Market Size by Application
7.3.1 Europe Renal Biomarkers Market Size by Application (2018-2023)
7.3.2 Europe Renal Biomarkers Market Size by Application (2024-2033)
7.3.3 Europe Renal Biomarkers Market Share by Application (2018-2033)
7.4 Europe Renal Biomarkers Market Size by Country
7.4.1 Europe Renal Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Renal Biomarkers Market Size by Country (2018-2023)
7.4.3 Europe Renal Biomarkers Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Renal Biomarkers Market Size (2018-2033)
8.2 China Renal Biomarkers Market Size by Type
8.2.1 China Renal Biomarkers Market Size by Type (2018-2023)
8.2.2 China Renal Biomarkers Market Size by Type (2024-2033)
8.2.3 China Renal Biomarkers Market Share by Type (2018-2033)
8.3 China Renal Biomarkers Market Size by Application
8.3.1 China Renal Biomarkers Market Size by Application (2018-2023)
8.3.2 China Renal Biomarkers Market Size by Application (2024-2033)
8.3.3 China Renal Biomarkers Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Renal Biomarkers Market Size (2018-2033)
9.2 Asia Renal Biomarkers Market Size by Type
9.2.1 Asia Renal Biomarkers Market Size by Type (2018-2023)
9.2.2 Asia Renal Biomarkers Market Size by Type (2024-2033)
9.2.3 Asia Renal Biomarkers Market Share by Type (2018-2033)
9.3 Asia Renal Biomarkers Market Size by Application
9.3.1 Asia Renal Biomarkers Market Size by Application (2018-2023)
9.3.2 Asia Renal Biomarkers Market Size by Application (2024-2033)
9.3.3 Asia Renal Biomarkers Market Share by Application (2018-2033)
9.4 Asia Renal Biomarkers Market Size by Region
9.4.1 Asia Renal Biomarkers Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Renal Biomarkers Market Size by Region (2018-2023)
9.4.3 Asia Renal Biomarkers Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Renal Biomarkers Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Type
10.2.1 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Renal Biomarkers Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Application
10.3.1 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Renal Biomarkers Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country
10.4.1 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Renal Biomarkers Introduction
11.1.4 Abbott Diagnostics Revenue in Renal Biomarkers Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Developments
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Renal Biomarkers Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Renal Biomarkers Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Developments
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Details
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Renal Biomarkers Introduction
11.3.4 Beckman Coulter Revenue in Renal Biomarkers Business (2018-2023)
11.3.5 Beckman Coulter Recent Developments
11.4 Siemens Healthcare Diagnostics
11.4.1 Siemens Healthcare Diagnostics Company Details
11.4.2 Siemens Healthcare Diagnostics Business Overview
11.4.3 Siemens Healthcare Diagnostics Renal Biomarkers Introduction
11.4.4 Siemens Healthcare Diagnostics Revenue in Renal Biomarkers Business (2018-2023)
11.4.5 Siemens Healthcare Diagnostics Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Renal Biomarkers Introduction
11.5.4 Thermo Fisher Scientific Revenue in Renal Biomarkers Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Astute Medical
11.6.1 Astute Medical Company Details
11.6.2 Astute Medical Business Overview
11.6.3 Astute Medical Renal Biomarkers Introduction
11.6.4 Astute Medical Revenue in Renal Biomarkers Business (2018-2023)
11.6.5 Astute Medical Recent Developments
11.7 BioMerieux SA
11.7.1 BioMerieux SA Company Details
11.7.2 BioMerieux SA Business Overview
11.7.3 BioMerieux SA Renal Biomarkers Introduction
11.7.4 BioMerieux SA Revenue in Renal Biomarkers Business (2018-2023)
11.7.5 BioMerieux SA Recent Developments
11.8 Randox Laboratories
11.8.1 Randox Laboratories Company Details
11.8.2 Randox Laboratories Business Overview
11.8.3 Randox Laboratories Renal Biomarkers Introduction
11.8.4 Randox Laboratories Revenue in Renal Biomarkers Business (2018-2023)
11.8.5 Randox Laboratories Recent Developments
11.9 Diagnostics A/S
11.9.1 Diagnostics A/S Company Details
11.9.2 Diagnostics A/S Business Overview
11.9.3 Diagnostics A/S Renal Biomarkers Introduction
11.9.4 Diagnostics A/S Revenue in Renal Biomarkers Business (2018-2023)
11.9.5 Diagnostics A/S Recent Developments
11.10 Sphingo Tec GmbH
11.10.1 Sphingo Tec GmbH Company Details
11.10.2 Sphingo Tec GmbH Business Overview
11.10.3 Sphingo Tec GmbH Renal Biomarkers Introduction
11.10.4 Sphingo Tec GmbH Revenue in Renal Biomarkers Business (2018-2023)
11.10.5 Sphingo Tec GmbH Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Renal Biomarkers Introduction
11.11.4 Eli Lilly and Company Revenue in Renal Biomarkers Business (2018-2023)
11.11.5 Eli Lilly and Company Recent Developments
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Renal Biomarkers Introduction
11.12.4 Novartis AG Revenue in Renal Biomarkers Business (2018-2023)
11.12.5 Novartis AG Recent Developments
11.13 Gentian Diagnostic
11.13.1 Gentian Diagnostic Company Details
11.13.2 Gentian Diagnostic Business Overview
11.13.3 Gentian Diagnostic Renal Biomarkers Introduction
11.13.4 Gentian Diagnostic Revenue in Renal Biomarkers Business (2018-2023)
11.13.5 Gentian Diagnostic Recent Developments
11.14 Proteomics International
11.14.1 Proteomics International Company Details
11.14.2 Proteomics International Business Overview
11.14.3 Proteomics International Renal Biomarkers Introduction
11.14.4 Proteomics International Revenue in Renal Biomarkers Business (2018-2023)
11.14.5 Proteomics International Recent Developments
11.15 BioPorto
11.15.1 BioPorto Company Details
11.15.2 BioPorto Business Overview
11.15.3 BioPorto Renal Biomarkers Introduction
11.15.4 BioPorto Revenue in Renal Biomarkers Business (2018-2023)
11.15.5 BioPorto Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Renal Biomarkers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 3. Key Players of Enzymatic Assay
Table 4. Key Players of Turbidimetric Immunoassay
Table 5. Key Players of Others
Table 6. Global Renal Biomarkers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Renal Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Renal Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Renal Biomarkers Market Share by Region (2018-2023)
Table 10. Global Renal Biomarkers Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Renal Biomarkers Market Share by Region (2024-2033)
Table 12. Renal Biomarkers Market Trends
Table 13. Renal Biomarkers Market Drivers
Table 14. Renal Biomarkers Market Challenges
Table 15. Renal Biomarkers Market Restraints
Table 16. Global Renal Biomarkers Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Renal Biomarkers Revenue Share by Players (2018-2023)
Table 18. Global Top Renal Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2022)
Table 19. Global Renal Biomarkers Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Renal Biomarkers Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Renal Biomarkers, Headquarters and Area Served
Table 22. Global Key Players of Renal Biomarkers, Product and Application
Table 23. Global Key Players of Renal Biomarkers, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Renal Biomarkers Revenue Market Share by Type (2018-2023)
Table 27. Global Renal Biomarkers Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Renal Biomarkers Revenue Market Share by Type (2024-2033)
Table 29. Global Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Renal Biomarkers Revenue Share by Application (2018-2023)
Table 31. Global Renal Biomarkers Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Renal Biomarkers Revenue Share by Application (2024-2033)
Table 33. North America Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Renal Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Renal Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Renal Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Renal Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Renal Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Renal Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Renal Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Renal Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Renal Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Renal Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Renal Biomarkers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Renal Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Renal Biomarkers Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Renal Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 65. Abbott Diagnostics Company Details
Table 66. Abbott Diagnostics Business Overview
Table 67. Abbott Diagnostics Renal Biomarkers Product
Table 68. Abbott Diagnostics Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 69. Abbott Diagnostics Recent Developments
Table 70. F. Hoffmann-La Roche Company Details
Table 71. F. Hoffmann-La Roche Business Overview
Table 72. F. Hoffmann-La Roche Renal Biomarkers Product
Table 73. F. Hoffmann-La Roche Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 74. F. Hoffmann-La Roche Recent Developments
Table 75. Beckman Coulter Company Details
Table 76. Beckman Coulter Business Overview
Table 77. Beckman Coulter Renal Biomarkers Product
Table 78. Beckman Coulter Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 79. Beckman Coulter Recent Developments
Table 80. Siemens Healthcare Diagnostics Company Details
Table 81. Siemens Healthcare Diagnostics Business Overview
Table 82. Siemens Healthcare Diagnostics Renal Biomarkers Product
Table 83. Siemens Healthcare Diagnostics Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 84. Siemens Healthcare Diagnostics Recent Developments
Table 85. Thermo Fisher Scientific Company Details
Table 86. Thermo Fisher Scientific Business Overview
Table 87. Thermo Fisher Scientific Renal Biomarkers Product
Table 88. Thermo Fisher Scientific Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 89. Thermo Fisher Scientific Recent Developments
Table 90. Astute Medical Company Details
Table 91. Astute Medical Business Overview
Table 92. Astute Medical Renal Biomarkers Product
Table 93. Astute Medical Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 94. Astute Medical Recent Developments
Table 95. BioMerieux SA Company Details
Table 96. BioMerieux SA Business Overview
Table 97. BioMerieux SA Renal Biomarkers Product
Table 98. BioMerieux SA Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 99. BioMerieux SA Recent Developments
Table 100. Randox Laboratories Company Details
Table 101. Randox Laboratories Business Overview
Table 102. Randox Laboratories Renal Biomarkers Product
Table 103. Randox Laboratories Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 104. Randox Laboratories Recent Developments
Table 105. Diagnostics A/S Company Details
Table 106. Diagnostics A/S Business Overview
Table 107. Diagnostics A/S Renal Biomarkers Product
Table 108. Diagnostics A/S Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 109. Diagnostics A/S Recent Developments
Table 110. Sphingo Tec GmbH Company Details
Table 111. Sphingo Tec GmbH Business Overview
Table 112. Sphingo Tec GmbH Renal Biomarkers Product
Table 113. Sphingo Tec GmbH Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 114. Sphingo Tec GmbH Recent Developments
Table 115. Eli Lilly and Company Company Details
Table 116. Eli Lilly and Company Business Overview
Table 117. Eli Lilly and Company Renal Biomarkers Product
Table 118. Eli Lilly and Company Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 119. Eli Lilly and Company Recent Developments
Table 120. Novartis AG Company Details
Table 121. Novartis AG Business Overview
Table 122. Novartis AG Renal Biomarkers Product
Table 123. Novartis AG Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 124. Novartis AG Recent Developments
Table 125. Gentian Diagnostic Company Details
Table 126. Gentian Diagnostic Business Overview
Table 127. Gentian Diagnostic Renal Biomarkers Product
Table 128. Gentian Diagnostic Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 129. Gentian Diagnostic Recent Developments
Table 130. Proteomics International Company Details
Table 131. Proteomics International Business Overview
Table 132. Proteomics International Renal Biomarkers Product
Table 133. Proteomics International Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 134. Proteomics International Recent Developments
Table 135. BioPorto Company Details
Table 136. BioPorto Business Overview
Table 137. BioPorto Renal Biomarkers Product
Table 138. BioPorto Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 139. BioPorto Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Biomarkers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Renal Biomarkers Market Share by Type: 2022 VS 2033
Figure 3. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 4. Enzymatic Assay Features
Figure 5. Turbidimetric Immunoassay Features
Figure 6. Others Features
Figure 7. Global Renal Biomarkers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Renal Biomarkers Market Share by Application: 2022 VS 2033
Figure 9. Diagnosis and Disease Progression Monitoring Case Studies
Figure 10. Research Case Studies
Figure 11. Others Case Studies
Figure 12. Renal Biomarkers Report Years Considered
Figure 13. Global Renal Biomarkers Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Renal Biomarkers Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Renal Biomarkers Market Share by Region: 2022 VS 2033
Figure 16. Global Renal Biomarkers Market Share by Players in 2022
Figure 17. Global Top Renal Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Renal Biomarkers Revenue in 2022
Figure 19. North America Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Renal Biomarkers Market Share by Type (2018-2033)
Figure 21. North America Renal Biomarkers Market Share by Application (2018-2033)
Figure 22. North America Renal Biomarkers Market Share by Country (2018-2033)
Figure 23. United States Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Renal Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Renal Biomarkers Market Share by Type (2018-2033)
Figure 27. Europe Renal Biomarkers Market Share by Application (2018-2033)
Figure 28. Europe Renal Biomarkers Market Share by Country (2018-2033)
Figure 29. Germany Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Renal Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Renal Biomarkers Market Share by Type (2018-2033)
Figure 37. China Renal Biomarkers Market Share by Application (2018-2033)
Figure 38. Asia Renal Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Renal Biomarkers Market Share by Type (2018-2033)
Figure 40. Asia Renal Biomarkers Market Share by Application (2018-2033)
Figure 41. Asia Renal Biomarkers Market Share by Region (2018-2033)
Figure 42. Japan Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Renal Biomarkers Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Renal Biomarkers Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Renal Biomarkers Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Renal Biomarkers Market Share by Country (2018-2033)
Figure 52. Brazil Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Abbott Diagnostics Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 60. Beckman Coulter Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 61. Siemens Healthcare Diagnostics Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 63. Astute Medical Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 64. BioMerieux SA Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 65. Randox Laboratories Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 66. Diagnostics A/S Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 67. Sphingo Tec GmbH Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 69. Novartis AG Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 70. Gentian Diagnostic Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 71. Proteomics International Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 72. BioPorto Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries